Literature DB >> 15125974

Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists.

Min Amy Xiang1, Robert H Chen, Keith T Demarest, Joseph Gunnet, Richard Look, William Hageman, William V Murray, Donald W Combs, Mona Patel.   

Abstract

A novel series of spirobenzazepines was synthesized and evaluated for V1a and V2 receptor antagonist activity. Compounds 8b, 8i, and 8k have shown selective V1a receptor antagonist activity. Compounds 8p and 8q were shown to be dual V1a/V2 receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15125974     DOI: 10.1016/j.bmcl.2004.02.103

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Azetidinones as vasopressin V1a antagonists.

Authors:  Christophe D Guillon; Gary A Koppel; Michael J Brownstein; Michael O Chaney; Craig F Ferris; Shi-Fang Lu; Karine M Fabio; Marvin J Miller; Ned D Heindel; David C Hunden; Robin D G Cooper; Stephen W Kaldor; Jeffrey J Skelton; Bruce A Dressman; Michael P Clay; Mitchell I Steinberg; Robert F Bruns; Neal G Simon
Journal:  Bioorg Med Chem       Date:  2006-12-23       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.